We’re not just changing how cancer care is delivered. We’re redefining what it means to heal.
To create a world where cancer prevention and recovery are intelligent, accessible, and life-changing.
Join the Waitlist“Sanare Oncology was born from a vision to reimagine cancer care—one where precision diagnostics, AI-powered insights, and human connection converge. Whether in genetics, imaging, biomarkers, or lived experience, your story holds insights. At Sanare Oncology, we translate that story into a roadmap using AI, expert care, and the healing power of nature and community. Transformation is not just possible—it’s personalized.”
Dr. Arisha Patel is a board-certified oncologist, physician-scientist, and data strategist with over a decade of leadership in precision oncology. She has led molecular trials, shaped national treatment guidelines, and helped pioneer the real-world integration of tumor-agnostic care and AI-powered diagnostics into clinical workflows.Through Sanare Oncology and its sister practice Sanare Hematology, she is reimagining what comes next—not just in treatment, but in the entire lifecycle of survivorship and prevention. Her mission is to infuse evidence-based science with real-time AI insights, longevity protocols, and whole-person digital care to deliver deeply transformative, human-centered cancer wellness.
Dr. Patel holds her MD from Chicago Medical School, completed fellowship at UPMC (a National Cancer Institute-designated Comprehensive Cancer Center and member of the National Comprehensive Cancer Network), and earned her MBA in Biomedical Entrepreneurship from Carnegie Mellon University. She has served as adjunct faculty at distinguished academic institutions, led strategy at pioneering biotech companies, and contributed to peer-reviewed publications shaping national precision oncology guidelines.A proud Texan and SMU alumna, she is devoted to building the future of compassionate, data-driven cancer care—and scaling access to life beyond diagnosis.
For media, strategic partnerships, or investor relations:
contact@sanareoncology.com
Our services are ideal for cancer survivors, individuals at high risk of developing cancer, those undergoing treatment who need additional support, and anyone looking for expert oncology care outside of traditional hospital settings.
We provide genetic risk assessments, lifestyle modification guidance, personalized screening plans, and ongoing health monitoring to reduce your risk of cancer.
While we don’t conduct testing in-house, we partner with leading laboratories to facilitate genetic testing and help interpret results, offering guidance on risk-reduction strategies.
Our team provides personalized recommendations on nutrition, exercise, stress management, and toxin avoidance to help reduce your cancer risk.
Yes! Based on your personal and family medical history, we create a customized screening schedule to ensure early detection of potential cancer risks.